Recent evidence from animal and human studies suggests that cerebrovascular dysfunctions, leading to blood–brain barrier (BBB) leakage, might also be associated with ApoE ε4 and AD pathology [13,14,15]. This evidence concerns the gene APOE and Alzheimer disease.